MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in LGND — Ligand Pharmaceuticals Inc
CIK 912938
Boston, MA
Position in LGND
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$82,164,559
-$13,697,523 QoQ
Shares Held
411,543
-18.8% QoQ
Ownership
2.05%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $1,374,765,738 across 53 Biotechnology names. LGND ranks #5 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,860,669 | $425,590,816 | |
| 2 | TECH |
BIO-TECHNE Corp
|
3,733,248 | $195,099,537 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
496,004 | $164,112,841 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
327,498 | $146,240,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
411,543 | $82,164,559 | |
| 6 | BNTX |
BioNTech SE
|
670,514 | $59,595,283 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
666,116 | $50,018,650 | |
| 8 | INCY |
Incyte Corp
|
410,729 | $38,657,809 |
All Filings in LGND
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,164,559 | 411,543 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $95,862,082 | 507,019 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $95,982,423 | 541,845 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $38,621,870 | 339,742 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $29,206,945 | 277,791 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $29,651,726 | 276,731 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||